Efficacy of golimumab in Belgian patients with active rheumatoid arthritis despite treatment with non-biologic disease-modifying anti-rheumatic drugs: sub-analysis of the GO-MORE study

Patrick Durez*, Marie Vanthuyne, Muhammad S. Soyfoo, Ilse Hoffman, Michel Malaise, Piet Geusens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)424-428
Number of pages5
JournalActa Clinica Belgica
Volume72
Issue number6
DOIs
Publication statusPublished - 2017

Keywords

  • Rheumatoid arthritis
  • Golimumab
  • Anti-rheumatic agents
  • Biological products
  • ADD-ON THERAPY
  • CLINICAL-PRACTICE
  • RECOMMENDATIONS
  • SAFETY

Cite this